Nearly 200 genes in the healthy prostate tissue of men with low-grade prostate cancer that might facilitate in explaining how exercise betters survival from the disease have been keyed by researchers.
In their study, scientists at the University of California, San Francisco (UCSF) compared the activity of some 20,000 genes in healthy prostate tissue biopsied from several dozen patients.
Aggresive Prostrate Cancer Treated Effectively With Surgery
Among patients with aggressive prostate cancer, there is a high survival rate of those who undergo surgery, reports a new study.
Advertisement
The finding builds on two studies last year by UCSF and Harvard School of Public Health that showed brisk walking or vigorous exercise such as jogging for three or more hours a week was linked to a lowered risk of prostate cancer progression and death after diagnosis.
Those earlier studies, however, offered no explanation as to why.
In the current work, the UCSF team teased out a molecular profile of 184 genes whose expression in the prostate gland is linked to vigorous exercise.
![Prostrate Cancer may be Warded Off by Walnuts]( "Prostrate Cancer may be Warded Off by Walnuts")
A new study has found that walnut consumption may help slow the growth of prostate cancer in mice.
Understanding how the activity of these genes is impacted by vigorous exercise and how this might translate to a lowered risk of prostate cancer progression may help reveal new ways to manage the disease, said the senior author of the study, June Chan, ScD, the Steven and Christine Burd-Safeway Distinguished Professor at UCSF.
"Vigorous physical activity may provide clinical benefits for men diagnosed with earlier stage prostate cancer," she said.
"The finding suggests some interesting leads on mechanisms by which physical activity may protect against prostate cancer progression."
The analysis involved examining the levels of expression, or activity, of the same 20,000 genes in 70 men. This information was correlated with the exercise patterns the men reported on questionnaires.
The study revealed 109 genes were "up-regulated," or more active, and 75 were "down-regulated" or less active, among the men who exercised vigorously for at least three hours a week compared to those who exercised less.
Among the genes that exhibited greater expression were a number that already are thought to help thwart cancer progression, including the well-known "tumor suppressor" genes BRCA1 and BRCA2, as well as genes involved in cell cycle and DNA repair.
Source: ANI
In the current work, the UCSF team teased out a molecular profile of 184 genes whose expression in the prostate gland is linked to vigorous exercise.
Prostrate Cancer may be Warded Off by Walnuts
A new study has found that walnut consumption may help slow the growth of prostate cancer in mice.
Advertisement
Understanding how the activity of these genes is impacted by vigorous exercise and how this might translate to a lowered risk of prostate cancer progression may help reveal new ways to manage the disease, said the senior author of the study, June Chan, ScD, the Steven and Christine Burd-Safeway Distinguished Professor at UCSF.
"Vigorous physical activity may provide clinical benefits for men diagnosed with earlier stage prostate cancer," she said.
"The finding suggests some interesting leads on mechanisms by which physical activity may protect against prostate cancer progression."
The analysis involved examining the levels of expression, or activity, of the same 20,000 genes in 70 men. This information was correlated with the exercise patterns the men reported on questionnaires.
The study revealed 109 genes were "up-regulated," or more active, and 75 were "down-regulated" or less active, among the men who exercised vigorously for at least three hours a week compared to those who exercised less.
Among the genes that exhibited greater expression were a number that already are thought to help thwart cancer progression, including the well-known "tumor suppressor" genes BRCA1 and BRCA2, as well as genes involved in cell cycle and DNA repair.
Source: ANI
First Prostrate Cancer Vaccine a Major Breakthrough: Indian Oncologist
Renowned oncologist Anuradha Hooda on Sunday said that the first vaccine to treat prostrate cancer Provenge, is a major scientific breakthrough in fighting the disease.
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Cancer News
The combination of the personalized cancer vaccine with ACT led to ovarian cancer control in few patients within a span of three months, stated study results.
Uncovering key kinases in tumor growth and invasion is crucial for improving targeted therapies in advanced-stage colorectal cancer.
The study findings validate metal-enhanced photo-oxidation for future metal-based anticancer drugs.
Mutations in 11 genes are linked to aggressive forms of prostate cancer, which may present novel therapeutic and therapy options.
Improved oral health, as indicated by the count of natural teeth and dental appointments preceding the diagnosis, correlated with enhanced head and neck cancer survival rates.
